NT5E and prostate carcinoma: CD73 has been shown to be expressed in tumor cells and in the stroma of colorectal cancer [37, 38], prostate cancer [39, 40], gastric cancer [41], breast cancer [42], ovarian cancer [43] and squamous cell carcinoma [44].